Support study for the evaluation of the Technology Transfer Block Exemption Regulation
Read more
03 Dec 2024
Read more
03 Dec 2024
Read more
17 Oct 2024
In this panel session experts from academia, the private sector, and the policy field delve into the challenges of assessing data value. Speakers: Marco Botta (European University Institute), Isabella De Michelis (ErnieApp Ltd), Cosimo Pacciani (Poste Italiane), Guillaume Duquesne (Compass Lexecon), Bruno Basalisco (Copenhagen Economics).
5 August 2023
In this panel session experts from academia, the private sector, and the policy field engage in a debate on interoperability and data portability. Speakers: Christian Reimsbach-Kounatze (OECD), Chris Jenkins (UK Competition and Market Authority), Chiara Caccinelli (ARCEP), Begoña Gonzalez Otero (Max Planck Institute for Innovation and Competition), Steffen Hoernig (Nova School of Business and Economics).
5 August 2023
In this panel session experts from academia, the private sector, and the policy field deliberate on the trade-offs between safeguarding and sharing personal data. Speakers: Danielle Da Costa Leite Borges (European University Institute), Katie O’Leary (Irish Data Protection Commission), Michèle Finck (University of Tübingen), Björn Herbers (CMS), Marco Pancini (Meta).
5 August 2023
MEP Vera Pilar del Castillo delivers an insightful keynote speech at a two-day conference titled "Global Data Governance".
5 August 2023
In the opening session of a two-day conference dedicated to global data governance, experts from academia, the private sector, and the policy realm delve into the economics of data sharing. Speakers: Pier Luigi Parcu (European University Institute), Anna Barker (ACCC), Antonio Manganelli (University of Rome Lumsa), Philipp Heller (NERA), Mario Denni (Brattle Group).
5 August 2023
Mr Paul Csiszár delivered the keynote speech concluding a high-level discussion on fair sharing and excessive prices at the intersection between competition law and regulated sectors such as pharma and telecom. In his speech, Mr Csiszár looked at the case of excessive prices of medicines from a competition law perspective.
28 March 2023
Affordable access to many drugs is made difficult by high prices. At the same time, serious questions arise about the degree of innovation and value offered by increasingly costly treatments. In this panel discussion, speakers look at the case of excessive prices of off-patent drugs and debate whether and to what extent competition authorities could also sanction excessive prices of drugs covered by patents.
28 March 2023